Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2.
Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer.
Chest roentgenographic abnormalities in IL-2 recipients. Incidence and correlation with clinical parameters.
Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients.
